Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (132)

2024

  1. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study

    European Journal of Heart Failure

  2. Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

    AIDS reviews, Vol. 25, Núm. 4, pp. 162-172

  3. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313

  4. Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort

    International Journal of Cardiology, Vol. 405

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Cardiogenic shock care in centers with an infarction code program but without cardiac surgery. Response

    Revista Espanola de Cardiologia

  3. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  4. Coinfection with Viral Hepatitis in HIV patients in 2023

    AIDS reviews, Vol. 25, Núm. 1, pp. 65-66

  5. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  6. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  7. Do Women Physicians Accept and Follow Heart Failure Guidelines More Than Men?

    Current Heart Failure Reports, Vol. 20, Núm. 3, pp. 151-156

  8. Early approach to LDL-related risk after acute coronary syndrome: the OPTA project

    Expert Review of Cardiovascular Therapy, Vol. 21, Núm. 6, pp. 373-378

  9. Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses

    European heart journal. Quality of care & clinical outcomes, Vol. 9, Núm. 2, pp. 194-202

  10. Frailty Is Common in Heart Transplant Candidates But Is Not Associated With Clinical Events and Is Reversible After Heart Transplantation

    American Journal of Cardiology, Vol. 205, pp. 28-34

  11. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  12. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  13. Opinion on the 2021 ESC guidelines on heart failure: a cross-sectional survey of 387 doctors

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 7-15

  14. Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 312-321

  15. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  16. Sex, Temporary Mechanical Circulatory Support, and Heart Transplantation: Insights From a Multi-Institutional Spanish Registry

    JACC: Heart Failure